[ad_1] Moderna and Merck released more positive three-year data Monday on their experimental vaccine, given to patients with the most deadly form of skin cancer […]
Continue readingTag: Moderna Inc
FDA approves Moderna's RSV vaccine for seniors, the company's second-ever product
[ad_1] The FDA has approved Moderna’s RSV vaccine for older adults. Courtesy: Moderna The Food and Drug Administration on Friday approved Moderna’s vaccine for respiratory […]
Continue reading
Healthy Returns: Pfizer, Merck, J&J and more to release cancer drug data at industry conference
[ad_1] Attendees walk through the lobby at the American Society of Clinical Oncology annual meeting in Chicago. Tim Boyle | Bloomberg | Getty Images Think […]
Continue reading
Here's how U.S. health officials are responding to bird flu in humans after second case
[ad_1] Cows are seen standing in a feedlot on June 14, 2023 in Quemado, Texas. Brandon Bell | Getty Images U.S. health officials are monitoring […]
Continue reading
The stock market gets nailed by the Fed, again. Plus, Starbucks' quiet comeback
[ad_1] Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour […]
Continue reading
Novavax stock jumps 50% as Sanofi deal kicks off turning point for struggling vaccine maker
[ad_1] A vial labeled “Novavax V Covid-19 Vaccine” is seen in this photo taken Jan. 16, 2022. Dado Ruvic | Reuters Shares of Novavax closed […]
Continue reading
Moderna says FDA delayed RSV vaccine approval to end of May
[ad_1] Nikos Pekiaridis | Lightrocket | Getty Images Moderna on Friday said the Food and Drug Administration has delayed the approval of its vaccine for […]
Continue reading
Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop combination shots
[ad_1] A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March […]
Continue reading
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
[ad_1] Nikos Pekiaridis | Nurphoto | Getty Images Moderna on Thursday posted a narrower-than-expected loss for the first quarter as the company’s cost-cutting efforts took […]
Continue reading
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
[ad_1] The exterior view of the entrance to Merck headquarters in Rahway, New Jersey, on Feb. 5, 2024. Spencer Platt | Getty Images Merck on […]
Continue reading